The latest financial statement is for the quarter ending 2026-01-23.
| Cash Flow | 2026-01-23 |
|---|---|
| Net loss | -132 |
| Depreciation and amortization | 117 |
| Provision for credit losses | 21 |
| Deferred income taxes | 1 |
| Stock-based compensation | 38 |
| Postretirement benefit plan expense | 6 |
| Asset write-offs | 84 |
| Other, net | -17 |
| Accounts receivable, net | 94 |
| Inventories | 93 |
| Accounts payable and accrued liabilities | -26 |
| Other operating assets and liabilities | -35 |
| Net cash (used in) provided by operating activities | -27 |
| Additions to property, plant, and equipment | 167 |
| Other investing activities, net | 10 |
| Net cash used in investing activities | -177 |
| Net transfers from parent | 204 |
| Other financing activities, net | 0 |
| Net cash provided by financing activities | 204 |
| Net change in cash and cash equivalents | 0 |
| Cash and cash equivalents at beginning of period | 11 |
| Cash and cash equivalents at end of period | 10 |
MiniMed Group, Inc. (MMED)
MiniMed Group, Inc. (MMED)